Cetaphil® Skin Care Products
March 2017: This action was dismissed When a complaint is dismissed with prejudice, it cannot be refiled., the reasons for which have not been disclosed.
September 2016: A false advertising class-action lawsuit was filed against Galderma Laboratories in September 2016 (and transferred to federal court in October 2016) for allegedly misleadingly representing that Cetaphil® skin care products treat or mitigate eczema when, in reality, they do not. (Greenberg et al v. Galderma Laboratories, L.P. and Does 1-100, Case No. 16-cv-6090, N. D. CA.)
Class-Action Tracker
The Latest
Billionaire Casino
Regulator finds TikTok ads misled consumers into thinking they could win real-world prizes.
TINA.org Files FTC & FDA Complaints Against Menopause Supplement Brands
An investigation into the menopause supplement industry by consumer advocacy organization truthinadvertising.org (TINA.org) has revealed a hotbed of deceptive advertising. The ad watchdog has amassed nearly 2,000 examples of problematic health…
The Menopause Deception Epidemic
How the supplement industry is taking advantage of women and what TINA.org is doing to fight it.
Consumer Alert: Menopause Supplements
Proceed with caution when it comes to menopause marketing.
TINA’s Take: Food Makers Should Disclose Animal-Derived Ingredients
TINA.org joins push for more transparency in food labeling.